300381 Stock Overview
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services biological enzyme preparations, biosynthetics, and nutrition and health products in China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Guangdong VTR Bio-Tech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.50 |
| 52 Week High | CN¥9.15 |
| 52 Week Low | CN¥3.53 |
| Beta | 0.30 |
| 1 Month Change | 31.81% |
| 3 Month Change | 42.86% |
| 1 Year Change | -17.58% |
| 3 Year Change | -24.55% |
| 5 Year Change | -21.30% |
| Change since IPO | 12.05% |
Recent News & Updates
Shareholder Returns
| 300381 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 52.4% | 4.6% | 4.2% |
| 1Y | -17.6% | -22.0% | -13.2% |
Return vs Industry: 300381 exceeded the CN Biotechs industry which returned -22% over the past year.
Return vs Market: 300381 underperformed the CN Market which returned -13.2% over the past year.
Price Volatility
| 300381 volatility | |
|---|---|
| 300381 Average Weekly Movement | 13.5% |
| Biotechs Industry Average Movement | 7.9% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300381's share price has been volatile over the past 3 months.
Volatility Over Time: 300381's weekly volatility has increased from 7% to 14% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 1,148 | Derong Zhou | vtrbiotech.com |
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services biological enzyme preparations, biosynthetics, and nutrition and health products in China. The company offers feed, energy, washing, food, papermaking, and textile enzymes, as well as biotechnology solutions. It also provides active natural products.
Guangdong VTR Bio-Tech Co., Ltd. Fundamentals Summary
| 300381 fundamental statistics | |
|---|---|
| Market cap | CN¥3.59b |
| Earnings (TTM) | CN¥22.56m |
| Revenue (TTM) | CN¥814.00m |
159.3x
P/E Ratio4.4x
P/S RatioIs 300381 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300381 income statement (TTM) | |
|---|---|
| Revenue | CN¥814.00m |
| Cost of Revenue | CN¥446.94m |
| Gross Profit | CN¥367.06m |
| Other Expenses | CN¥344.50m |
| Earnings | CN¥22.56m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.047 |
| Gross Margin | 45.09% |
| Net Profit Margin | 2.77% |
| Debt/Equity Ratio | 3.1% |
How did 300381 perform over the long term?
See historical performance and comparison